The role of myostatin in muscle wasting: an overview
Open Access
- 26 July 2011
- journal article
- research article
- Published by Wiley in Journal of Cachexia, Sarcopenia and Muscle
- Vol. 2 (3), 143-151
- https://doi.org/10.1007/s13539-011-0035-5
Abstract
Myostatin is an extracellular cytokine mostly expressed in skeletal muscles and known to play a crucial role in the negative regulation of muscle mass. Upon the binding to activin type IIB receptor, myostatin can initiate several different signalling cascades resulting in the upregulation of the atrogenes and downregulation of the important for myogenesis genes. Muscle size is regulated via a complex interplay of myostatin signalling with the insulin-like growth factor 1/phosphatidylinositol 3-kinase/Akt pathway responsible for increase in protein synthesis in muscle. Therefore, the regulation of muscle weight is a process in which myostatin plays a central role but the mechanism of its action and signalling cascades are not fully understood. Myostatin upregulation was observed in the pathogenesis of muscle wasting during cachexia associated with different diseases (i.e. cancer, heart failure, HIV). Characterisation of myostatin signalling is therefore a perspective direction in the treatment development for cachexia. The current review covers the present knowledge about myostatin signalling pathways leading to muscle wasting and the state of therapy approaches via the regulation of myostatin and/or its downstream targets in cachexia.Keywords
This publication has 106 references indexed in Scilit:
- Cachexia in heart disease: highlights from the ESC 2010Journal of Cachexia, Sarcopenia and Muscle, 2011
- An overview of sarcopenia: facts and numbers on prevalence and clinical impactJournal of Cachexia, Sarcopenia and Muscle, 2010
- Ghrelin and its potential in the treatment of eating/wasting disorders and cachexiaJournal of Cachexia, Sarcopenia and Muscle, 2010
- Ghrelin for cachexiaJournal of Cachexia, Sarcopenia and Muscle, 2010
- Ethical guidelines for authorship and publishing in the Journal of Cachexia, Sarcopenia and MuscleJournal of Cachexia, Sarcopenia and Muscle, 2010
- Mechanisms involved in the enhancement of mammalian target of rapamycin signalling and hypertrophy in skeletal muscle of myostatin‐deficient miceFEBS Letters, 2010
- Non-Smad pathways in TGF-β signalingCell Research, 2008
- Fast/Glycolytic Muscle Fiber Growth Reduces Fat Mass and Improves Metabolic Parameters in Obese MiceCell Metabolism, 2008
- A deletion in the bovine myostatin gene causes the double–muscled phenotype in cattleNature Genetics, 1997
- Mechanism of activation of the TGF-β receptorNature, 1994